Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ISRCTN16907860) titled 'Comparing pain during pessary change: sitting position versus side-lying p... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061325) titled 'The Relationship Between Well-Being and Psychophysiological Functions Whil... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061324) titled 'Evaluation of Biological Age using Salivary HSP70 and its Association with... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061323) titled 'Comparison of Ultrasound-Guided Bilateral re-M-TAPA Block and Surgical Wou... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061319) titled 'Development of coordination between hospitals and clinics using an IBD app... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061318) titled 'A prospective multicenter observational study investigating the associatio... Read More
Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061110) titled 'Effects of participation in community sports clubs on overall motor compet... Read More
Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 19 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More